Leo Cancer Care Announces Commercial Collaboration with Leading Healthcare Solutions Provider to Bring Connected Imaging and Radiation Therapy Workflows to Market
MIDDLETON, Wis., Aug. 28, 2026 /PRNewswire/ -- Leo Cancer Care, a pioneer in upright radiation therapy, today announced a commercial collaboration with GE HealthCare, a leading healthcare solutions provider. Under the agreement, the two companies intend to work together on GE HealthCare's...
Covered in this story
What has happened since
- GE HealthCare is down 2.0% since this was published, 53 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on GE HealthCare
- Needham: $65.1 → $93 by Oct 2027 · Buy via Investing.com
- RBC Capital Markets: $65.1 → $80 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $GEHC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on GE HealthCare →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.